RE: Tick Tock22 Dec 2021 08:32
krafty,
Yes, we will obviously need to partner. There may be a financial case for going it alone but this would simply take far too long and meanwhile people are dying and economies are being wrecked.
At this early stage, we would need substantial support and this would be reflected in the royalty share we receive. Even so, the figures are eye watering (or mouth watering!)
The global Covid19 vaccine market is projected to be worth $150B per year.
Let's be ultra conservative on the projections and call it $100B per year.
We get 5% of that market and a 10% royalty on those sales = $500M/£378M per year
Using 915M shares in issue, that is an earning of 38p per share.
So, lets say LD wants to retain 50% for further research, they could pay a 19p dividend per share (a 100% return on todays SP).
Or, using a PE of 10, you could sell your shares for £3.80 each.
Even if you factor in a risk factor of 10%, these ought to be trading at 38p today. That's on Covidity alone!
AIMO